Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/19150580

Download in:

View as

General Info

PMID
19150580